China Resources Pharmaceutical Group Ltd.
3320
Hisse Senetlerindeki Sıralama
#4246
China Resources Pharmaceutical Group Limited, an investment holding company,... China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Hisse Fiyatı
$0.5954966
Son senkronizasyon: 2026-10-20
Piyasa Değeri
$3.74B
Değişim (1 gün)
1.09%
Değişim (1 yıl)
-3.38%
Ülke
HK
Ticaret China Resources Pharmaceutical Group Ltd. (3320)
Kategori
Healthcare
China Resources Pharmaceutical Group Ltd. (3320) için kazanç
Jun 2026 itibarıyla kazanç TTM: $1.71B
China Resources Pharmaceutical Group Ltd. şirketinin en son finansal raporlarına göre, mevcut kazancı $1.71B'dir. 2023 yılında şirket $1.39B kazanç elde etti, bu 2022 yılındaki $1.26B kazanca göre önceki yıla göre artış. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
China Resources Pharmaceutical Group Ltd. için kazanç geçmişi 2013 - 2026
Her yılın sonundaki kazanç
| Yıl | Kazanç | Değiştir |
|---|---|---|
| 2026 (TTM) | $1.71B | 13.87% |
| 2024 | $1.50B | 7.62% |
| 2023 | $1.39B | 10.35% |
| 2022 | $1.26B | 16.96% |
| 2021 | $1.08B | 18.19% |
| 2020 | $912.56M | 9.36% |
| 2019 | $834.45M | -28.83% |
| 2018 | $1.17B | 6.72% |
| 2017 | $1.10B | 5.89% |
| 2016 | $1.04B | -0.13% |
| 2015 | $1.04B | 16.37% |
| 2014 | $892.63M | 0.13% |
| 2013 | $891.51M | 0.00% |
Benzer şirketler veya rakipler için kazanç
| Şirket | Kazanç | Kazanç Farkı | Ülke |
|---|---|---|---|
| $1.35B | -20.87% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $26.37M | -98.45% |
US
|
